profit
Biogen Raises Profit Guidance Amid Leqembi Growth and MS Sales Decline
Biogen, profit guidance, Leqembi, multiple sclerosis, earnings report, pharmaceutical industry
Biogen Lifts Outlook as Leqembi Sales Accelerate in Q2
Biogen, Leqembi, Q2 earnings, Alzheimer’s drug, cost cuts, profit outlook
Elevance Health Surpasses Expectations in Q2 with $2.3 Billion Profit
Elevance Health, Q2 earnings, profit, revenue, Carelon, PBM, insurance premiums
Takeda Pharmaceuticals Revises Profit Forecast Due to Vyvanse Patent Expiration, Plans $900M Restructuring by 2024
Takeda Pharmaceuticals, Vyvanse, patent expiration, profit outlook, restructuring, ADHD medication